Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

A two-in-one mRNA vaccine developed by Moderna that targets seasonal influenza and COVID-19 produced robust and durable immune responses without safety concerns in a small mid-stage trial, the company... ...